Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | 1,197 | 0 |
| TOTAL | $N/A | $2,005 | $0 |
| Non-Current Assets | |||
| Investments And Advances | 0 | 230,000 | 0 |
| TOTAL | $N/A | $230,000 | $N/A |
| Total Assets | $N/A | $232,005 | $0 |
| Liabilities | |||
| Current Liabilities | |||
| Accrued Expenses | N/A | 48 | 0 |
| TOTAL | $N/A | $48 | $0 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 250,933 | 0 |
| TOTAL | $N/A | $250,933 | $N/A |
| Total Liabilities | $N/A | $250,981 | $0 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 239 | 239 | N/A |
| Common Shares | N/A | 1 | 0 |
| Retained earnings | N/A | -18,976 | 0 |
| TOTAL | $N/A | $-18,975 | $0 |
| Total Liabilities And Equity | $0 | $232,005 | $0 |